Vor Biopharma Inc.(VOR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VOR Vor Biopharma Inc.

未开盘 07-10 16:00:00 EDT

2.31

-0.23

-9.06%

盘后2.40

+0.09+3.90%

19:59 EDT

最高2.64	最低2.25	成交量1,269万
今开2.60	昨收2.54	日振幅15.35%
总市值2.89亿	流通市值9,019万	总股本1.25亿
成交额3,023万	换手率32.51%	流通股本3,904万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VOR","market":"US","secType":"STK","nameCN":"Vor Biopharma Inc.","latestPrice":2.31,"timestamp":1752177600000,"preClose":2.54,"halted":0,"volume":12691388,"hourTrading":{"tag":"盘后","latestPrice":2.4,"preClose":2.31,"latestTime":"19:59 EDT","volume":273962,"amount":657663.4182,"timestamp":1752191962111},"delay":0,"floatShares":39043539,"shares":124959520,"eps":-1.430523,"marketStatus":"未开盘","change":-0.23,"latestTime":"07-10 16:00:00 EDT","open":2.6,"high":2.64,"low":2.25,"amount":30226416.3091464,"amplitude":0.153543,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.430523,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752220800000},"marketStatusCode":0,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":2.54,"preHourTrading":{"tag":"盘前","latestPrice":2.64,"preClose":2.54,"latestTime":"09:29 EDT","volume":317566,"amount":846991.9332721999,"timestamp":1752154179999},"postHourTrading":{"tag":"盘后","latestPrice":2.4,"preClose":2.31,"latestTime":"19:59 EDT","volume":273962,"amount":657663.4182,"timestamp":1752191962111},"volumeRatio":0.425335,"impliedVol":2.2015,"impliedVolPercentile":0.904},"requestUrl":"/m/hq/s/VOR","defaultTab":"news","newsList":[{"id":"1103054559","title":"Form 144 | VOR BIOPHARMA INC. 高管 Robert Ang 拟减持596885股，总价约138.8万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1103054559","media":"老虎公告助手","labels":["insiderTrades"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103054559?lang=zh_cn&edition=full","pubTime":"2025-07-11 04:25","pubTimestamp":1752179117,"startTime":"0","endTime":"0","summary":"VOR BIOPHARMA INC. 高管 Robert Ang 拟于美东时间2025年7月10日出售596885股普通股，总市值约138.8万美元。过去3个月内，Robert Ang 已累计发生过多次减持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Form 144 | VOR BIOPHARMA INC. 高管 Robert Ang 拟减持596885股，总价约138.8万美元","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR"],"gpt_icon":0},{"id":"2550625950","title":"Vor Biopharma Inc.盘中异动 早盘股价大跌5.12%报2.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550625950","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550625950?lang=zh_cn&edition=full","pubTime":"2025-07-10 21:36","pubTimestamp":1752154579,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日21时36分，Vor Biopharma Inc.股票出现波动，股价大幅跳水5.12%。截至发稿，该股报2.41美元/股，成交量177.752万股，换手率1.42%，振幅7.87%。Vor Biopharma Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Cognition Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma, Inc.涨幅较大，Cognition Therapeutics, Inc.、Klotho Neurosciences, Inc.、Nucana Plc较为活跃，换手率分别为211.73%、120.30%、62.00%，振幅较大的相关个股有Cognition Therapeutics, Inc.、Neonc Technologies Holdings, Inc.、Nurix Therapeutics, Inc.，振幅分别为29.21%、23.47%、14.42%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc是一家临床阶段细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213620a6a1c2c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213620a6a1c2c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":1},{"id":"2550961269","title":"Vor Biopharma Inc.7月9日成交额为5140.91万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550961269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550961269?lang=zh_cn&edition=full","pubTime":"2025-07-10 15:44","pubTimestamp":1752133457,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，Vor Biopharma Inc.成交额为5140.91万美元，成交额较昨日减少37.75%，当日成交量为1899.30万股。Vor Biopharma Inc.于2025年7月9日涨5.83%，报2.54美元，该股过去5个交易日涨77.62%，年初至今涨128.83%，过去60日涨307.05%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-09|5140.91万|-37.75%|1899.30万|#|2025-07-08|8258.06万|-36.99%|3088.90万|#|2025-07-07|1.31亿|209.34%|4949.49万|#|2025-07-03|4236.67万|5.05%|2449.19万|#|2025-07-02|4033.16万|-39.33%|2532.41万|Vor Biopharma Inc是一家临床阶段细胞治疗公司。公司产品包括VCAR33、Tremcel和骨髓增生异常综合征、Trem-cel+VCAR33治疗系统、VADC45、CD123、CLL1、EMR2。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710160036a6a115cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710160036a6a115cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":1},{"id":"2550899976","title":"Vor Biopharma Inc.7月8日成交额为8258.06万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550899976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550899976?lang=zh_cn&edition=full","pubTime":"2025-07-09 15:39","pubTimestamp":1752046754,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日，Vor Biopharma Inc.成交额为8258.06万美元，成交额较昨日减少36.99%，当日成交量为3088.90万股。Vor Biopharma Inc.于2025年7月8日跌10.11%，报2.4美元，该股过去5个交易日涨48.15%，年初至今涨116.22%，过去60日涨315.22%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-08|8258.06万|-36.99%|3088.90万|#|2025-07-07|1.31亿|209.34%|4949.49万|#|2025-07-03|4236.67万|5.05%|2449.19万|#|2025-07-02|4033.16万|-39.33%|2532.41万|#|2025-07-01|6647.61万|-33.42%|3885.39万|Vor Biopharma Inc是一家临床阶段细胞治疗公司。公司产品包括VCAR33、Tremcel和骨髓增生异常综合征、Trem-cel+VCAR33治疗系统、VADC45、CD123、CLL1、EMR2。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709155125a69eddcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709155125a69eddcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":1},{"id":"2549530453","title":"Vor Biopharma Inc.盘中异动 大幅上涨7.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549530453","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549530453?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:32","pubTimestamp":1751895133,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时32分，Vor Biopharma Inc.股票出现波动，股价快速拉升7.11%。截至发稿，该股报2.05美元/股，成交量316.394万股，换手率2.53%，振幅7.32%。Vor Biopharma Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为1382.66%、746.68%、658.43%，振幅较大的相关个股有Mustang Bio, Inc.、Nucana Plc、湖岸生物，振幅分别为20.17%、11.94%、10.05%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc是一家临床阶段细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213214a43bf665&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213214a43bf665&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":1},{"id":"2548607865","title":"Vor Biopharma Inc.7月1日成交额为6647.61万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548607865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548607865?lang=zh_cn&edition=full","pubTime":"2025-07-02 15:01","pubTimestamp":1751439665,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，Vor Biopharma Inc.成交额为6647.61万美元，成交额较昨日减少33.42%，当日成交量为3885.39万股。Vor Biopharma Inc.于2025年7月1日跌11.73%，报1.43美元，该股过去5个交易日涨349.69%，年初至今涨28.83%，过去60日涨142.37%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-01|6647.61万|-33.42%|3885.39万|#|2025-06-30|9984.57万|90.83%|6700.42万|#|2025-06-27|5232.10万|-81.44%|4895.45万|#|2025-06-26|2.82亿|223.93%|2.83亿|#|2025-06-25|8703.01万|120.14%|1.72亿|Vor Biopharma Inc是一家临床阶段细胞治疗公司。公司产品包括VCAR33、Tremcel和骨髓增生异常综合征、Trem-cel+VCAR33治疗系统、VADC45、CD123、CLL1、EMR2。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702150112a729f6ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702150112a729f6ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2547092733","title":"Vor Biopharma Inc.盘中异动 大幅拉升13.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547092733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547092733?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:32","pubTimestamp":1751290351,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时32分，Vor Biopharma Inc.股票出现异动，股价快速拉升13.20%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc是一家临床阶段细胞治疗公司。消息层面，截至21时32分，《荣昌生物泰它西普“出海”三问》资讯为影响Vor Biopharma Inc.的重要信息。事实上，荣昌生物通过本次交易获得23%的股权，将使其跃居Vor Biopharma最大股东之一，而非只是扮演“技术入股投资者”的角色。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213232a4c6c4d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213232a4c6c4d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":1},{"id":"2546337771","title":"Vor Biopharma Inc.6月27日成交额为5232.10万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546337771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546337771?lang=zh_cn&edition=full","pubTime":"2025-06-28 14:48","pubTimestamp":1751093326,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，Vor Biopharma Inc.成交额为5232.10万美元，成交额较昨日减少81.44%，当日成交量为4895.45万股。Vor Biopharma Inc.于2025年6月27日涨19.1%，报1.06美元，该股过去5个交易日涨341.67%，年初至今跌4.5%，过去60日涨70.97%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-27|5232.10万|-81.44%|4895.45万|#|2025-06-26|2.82亿|223.93%|2.83亿|#|2025-06-25|8703.01万|120.14%|1.72亿|#|2025-06-24|3953.43万|227.97%|9815.48万|#|2025-06-23|1205.44万|705.98%|3699.94万|Vor Biopharma Inc是一家临床阶段细胞治疗公司。公司产品包括VCAR33、Tremcel和骨髓增生异常综合征、Trem-cel+VCAR33治疗系统、VADC45、CD123、CLL1、EMR2。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628144853a72239cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628144853a72239cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":1},{"id":"2546016731","title":"Abvc Biopharma, Inc.盘中异动 股价大涨5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546016731","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546016731?lang=zh_cn&edition=full","pubTime":"2025-06-26 22:23","pubTimestamp":1750947824,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日22时23分，Abvc Biopharma, Inc.股票出现波动，股价急速拉升5.66%。Abvc Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Vor Biopharma Inc.、Adial Pharmaceuticals, Inc、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.、Vor Biopharma Inc.较为活跃，换手率分别为1005.27%、230.24%、101.44%，振幅较大的相关个股有Vor Biopharma Inc.、Apollomics Inc C/Wts 01/04/2028 、Vyne Therapeutics Inc.，振幅分别为91.63%、40.05%、28.10%。Abvc Biopharma, Inc.公司简介：ABVC BioPharma Inc 是一家临床阶段生物制药公司，目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626222344952cc705&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626222344952cc705&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVC","VOR","BK4139"],"gpt_icon":0},{"id":"2546340057","title":"Geovax Labs Inc C/Wts 29/09/2025(To Pur Com)盘中异动 早盘股价大涨29.21%报0.026美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546340057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546340057?lang=zh_cn&edition=full","pubTime":"2025-06-26 22:19","pubTimestamp":1750947592,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日22时19分，Geovax Labs Inc C/Wts 29/09/2025股票出现异动，股价大幅拉升29.21%。Geovax Labs Inc C/Wts 29/09/2025股票所在的生物技术行业中，整体跌幅为0.23%。Geovax Labs Inc C/Wts 29/09/2025公司简介：Geovax Labs Inc 是一家临床阶段的生物技术公司，使用新颖的专有平台开发针对传染病和实体瘤癌症的人类疫苗和免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626221952a71f0bd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626221952a71f0bd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOVXW","BK4139","VOR"],"gpt_icon":0},{"id":"2546173115","title":"Rocket Pharmaceuticals Inc C/Wts 02/09/2026 (To Pur Com)盘中异动 早盘大幅跳水10.78%报0.036美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546173115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546173115?lang=zh_cn&edition=full","pubTime":"2025-06-26 22:03","pubTimestamp":1750946618,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日22时03分，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 股票出现波动，股价大幅下挫10.78%。Rocket Pharmaceuticals Inc C/Wts 02/09/2026 股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Adial Pharmaceuticals, Inc、Vor Biopharma Inc.、Vyne Therapeutics Inc.涨幅较大，Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.、Vor Biopharma Inc.较为活跃，换手率分别为899.41%、214.51%、82.86%，振幅较大的相关个股有Vor Biopharma Inc.、Apollomics Inc C/Wts 01/04/2028 、Vyne Therapeutics Inc.，振幅分别为91.63%、40.05%、26.64%。Rocket Pharmaceuticals Inc C/Wts 02/09/2026 公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626220338a4bf5584&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626220338a4bf5584&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","RCKTW","BK4139"],"gpt_icon":0},{"id":"2546316977","title":"Equillium, Inc.盘中异动 快速跳水6.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546316977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546316977?lang=zh_cn&edition=full","pubTime":"2025-06-26 21:56","pubTimestamp":1750946162,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日21时56分，Equillium, Inc.股票出现异动，股价急速跳水6.41%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506262156029790058e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506262156029790058e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EQ","BK4568","VOR"],"gpt_icon":0},{"id":"2546206990","title":"Vor Biopharma Inc.6月25日成交额为8703.01万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546206990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546206990?lang=zh_cn&edition=full","pubTime":"2025-06-26 15:01","pubTimestamp":1750921286,"startTime":"0","endTime":"0","summary":"美东时间2025年6月25日，Vor Biopharma Inc.成交额为8703.01万美元，成交额较昨日增加120.14%，当日成交量为1.72亿股。Vor Biopharma Inc.于2025年6月25日涨74.28%，报0.554美元，该股过去5个交易日涨169.13%，年初至今跌50.05%，过去60日跌26.37%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-25|8703.01万|120.14%|1.72亿|#|2025-06-24|3953.43万|227.97%|9815.48万|#|2025-06-23|1205.44万|705.98%|3699.94万|#|2025-06-20|149.56万|468.52%|612.17万|#|2025-06-18|26.31万|17.43%|121.60万|Vor Biopharma Inc是一家临床阶段细胞治疗公司。公司产品包括VCAR33、Tremcel和骨髓增生异常综合征、Trem-cel+VCAR33治疗系统、VADC45、CD123、CLL1、EMR2。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626150131a71e5c8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626150131a71e5c8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2545417374","title":"Vor Biopharma Inc.盘中异动 早盘急速拉升8.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545417374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545417374?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:31","pubTimestamp":1750685507,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时31分，Vor Biopharma Inc.股票出现异动，股价快速拉升8.16%。截至发稿，该股报0.260美元/股，成交量131.974万股，换手率1.06%，振幅12.44%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Cidara Therapeutics, Inc.涨幅较大，Indaptus Therapeutics, Inc.、Impact Biomedical, Inc.、Nucana Plc较为活跃，换手率分别为887.27%、877.37%、197.17%，振幅较大的相关个股有Impact Biomedical, Inc.、Cero Therapeutics Holdings, Inc.、Bioatla, Inc.，振幅分别为24.86%、14.61%、12.11%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc是一家临床阶段细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213147a718f0d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213147a718f0d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2543060850","title":"Vor Biopharma Inc.盘中异动 大幅拉升8.29%报0.197美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543060850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543060850?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:33","pubTimestamp":1750080813,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时33分，Vor Biopharma Inc.股票出现异动，股价大幅上涨8.29%。截至发稿，该股报0.197美元/股，成交量38.1607万股，换手率0.31%，振幅5.11%。Vor Biopharma Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc是一家临床阶段细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506162133339781ecaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506162133339781ecaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2543639912","title":"Vor Biopharma Inc.盘中异动 大幅下跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543639912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543639912?lang=zh_cn&edition=full","pubTime":"2025-06-14 00:48","pubTimestamp":1749833336,"startTime":"0","endTime":"0","summary":"北京时间2025年06月14日00时48分，Vor Biopharma Inc.股票出现波动，股价快速跳水5.41%。截至发稿，该股报0.196美元/股，成交量58.9682万股，换手率0.47%，振幅7.34%。Vor Biopharma Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc是一家临床阶段细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614004857977e79df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614004857977e79df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2542380033","title":"Vor Biopharma Inc.盘中异动 早盘股价大跌5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542380033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542380033?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:33","pubTimestamp":1749476014,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时33分，Vor Biopharma Inc.股票出现波动，股价快速下挫5.76%。截至发稿，该股报0.211美元/股，成交量6.7297万股，换手率0.05%，振幅4.47%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.62%。其相关个股中，Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Pmgc Holdings Inc.、Klotho Neurosciences, Inc.、Synaptogenix, Inc.较为活跃，换手率分别为1013.34%、933.08%、632.33%，振幅较大的相关个股有Metsera, Inc.、Tenaya Therapeutics, Inc.、Polyrizon Ltd.，振幅分别为128.01%、115.45%、110.70%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc是一家临床阶段细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092133359777e72c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092133359777e72c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2540791366","title":"Vor Biopharma Inc.盘中异动 大幅拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540791366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540791366?lang=zh_cn&edition=full","pubTime":"2025-06-02 22:40","pubTimestamp":1748875244,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日22时40分，Vor Biopharma Inc.股票出现异动，股价大幅上涨5.05%。截至发稿，该股报0.210美元/股，成交量94.8794万股，换手率0.76%，振幅5.30%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为1.07%。其相关个股中，Lyra Therapeutics, Inc.、Oragenics Inc.、Immatics N V C/Wts 01/07/2025 涨幅较大，Lyra Therapeutics, Inc.、Oragenics Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为1426.47%、1013.39%、328.67%，振幅较大的相关个股有Lyra Therapeutics, Inc.、Oragenics Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为248.28%、98.58%、80.43%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc是一家临床阶段细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602224044a6f733f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602224044a6f733f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2537324751","title":"Vor Biopharma Inc.盘中异动 早盘大幅下跌5.19%报0.177美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537324751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537324751?lang=zh_cn&edition=full","pubTime":"2025-05-23 21:48","pubTimestamp":1748008091,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日21时48分，Vor Biopharma Inc.股票出现波动，股价快速下挫5.19%。截至发稿，该股报0.177美元/股，成交量26.4882万股，换手率0.21%，振幅8.67%。Vor Biopharma Inc.股票所在的生物技术行业中，整体跌幅为0.80%。其相关个股中，Imunon, Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Dermata Therapeutics Inc C/Wts 涨幅较大，Polyrizon Ltd.、Imunon, Inc.、Nucana Plc较为活跃，换手率分别为1782.34%、1269.89%、478.51%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Imunon, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为106.67%、62.58%、50.00%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc是一家临床阶段细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523214811aa2c9846&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523214811aa2c9846&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2536418646","title":"Vor Biopharma Inc.盘中异动 早盘快速上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536418646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536418646?lang=zh_cn&edition=full","pubTime":"2025-05-20 23:21","pubTimestamp":1747754483,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日23时21分，Vor Biopharma Inc.股票出现波动，股价快速上涨5.13%。截至发稿，该股报0.185美元/股，成交量64.2145万股，换手率0.51%，振幅5.87%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Neuraxis, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Polyrizon Ltd.、Eyenovia, Inc.、Neuraxis, Inc.较为活跃，换手率分别为3896.10%、1473.51%、1000.09%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd C/Wts 25/01/2029、Neuraxis, Inc.，振幅分别为174.55%、95.65%、85.46%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc是一家临床阶段细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052023212394fcd9b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052023212394fcd9b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vorbio.com","stockEarnings":[{"period":"1week","weight":0.2094},{"period":"1month","weight":9.0654},{"period":"3month","weight":2.3},{"period":"6month","weight":0.4855},{"period":"1year","weight":1.447},{"period":"ytd","weight":1.0811}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vor Biopharma Inc.于2015年12月30日在特拉华州注册成立为PureTech Health LLC的全资子公司。该公司是一家临床阶段的细胞疗法公司，结合了新颖的患者工程方法和靶向疗法，为患有血液系统恶性肿瘤的患者提供了单一的公司解决方案。该公司的专有平台利用其在造血干细胞生物学，基因组工程和靶向疗法开发方面的专业知识，对HSC进行基因修饰，以去除癌细胞表达的表面靶标。Vor总部位于马萨诸塞州剑桥。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.049009},{"month":2,"riseRate":0.5,"avgChangeRate":-0.021517},{"month":3,"riseRate":0.2,"avgChangeRate":-0.142709},{"month":4,"riseRate":0,"avgChangeRate":-0.179628},{"month":5,"riseRate":0.2,"avgChangeRate":-0.276218},{"month":6,"riseRate":0.4,"avgChangeRate":1.31333},{"month":7,"riseRate":0.2,"avgChangeRate":-0.01381},{"month":8,"riseRate":0.5,"avgChangeRate":0.013788},{"month":9,"riseRate":0.25,"avgChangeRate":-0.127012},{"month":10,"riseRate":0.75,"avgChangeRate":0.068664},{"month":11,"riseRate":0.25,"avgChangeRate":-0.077067},{"month":12,"riseRate":1,"avgChangeRate":0.250694}],"exchange":"NASDAQ","name":"Vor Biopharma Inc.","nameEN":"Vor Biopharma Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vor Biopharma Inc.(VOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Vor Biopharma Inc.(VOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Vor Biopharma Inc.,VOR,Vor Biopharma Inc.股票,Vor Biopharma Inc.股票老虎,Vor Biopharma Inc.股票老虎国际,Vor Biopharma Inc.行情,Vor Biopharma Inc.股票行情,Vor Biopharma Inc.股价,Vor Biopharma Inc.股市,Vor Biopharma Inc.股票价格,Vor Biopharma Inc.股票交易,Vor Biopharma Inc.股票购买,Vor Biopharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vor Biopharma Inc.(VOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Vor Biopharma Inc.(VOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}